When the side effect helps the treatment: graft-versus-tumor

K Smigel. J Natl Cancer Inst. 1993.

. 1993 Jun 2;85(11):855-6.

doi: 10.1093/jnci/85.11.855.

No abstract available

Similar articles

Bone marrow transplantation and graft-versus-host disease.
Powles RL. Powles RL. Curr Opin Immunol. 1989-1990;2(6):870-5. Curr Opin Immunol. 1989. PMID: 2486567 Review. No abstract available.
T cells, graft-versus-host disease and graft-versus-leukemia: innovative approaches for blood and marrow transplantation.
Champlin R, Giralt S, Gajewski J. Champlin R, et al. Acta Haematol. 1996;95(3-4):157-63. doi: 10.1159/000203871. Acta Haematol. 1996. PMID: 8677736 Review.
Graft-versus-leukemia activity after T-cell depletion using counterflow centrifugation.
de Witte T, Preijers F, Schattenberg A. de Witte T, et al. Bone Marrow Transplant. 1990 Jul;6 Suppl 1:103-5. Bone Marrow Transplant. 1990. PMID: 2202463 Review. No abstract available.
Treatment of leukemia by marrow transplantation from HLA incompatible donors. Effect of HLA-disparity on GVHD, relapse and survival.
Hansen JA, Anasetti C, Beatty PG, Martin PJ, Sanders JE, Storb R, Thomas ED. Hansen JA, et al. Bone Marrow Transplant. 1990 Jul;6 Suppl 1:108-11. Bone Marrow Transplant. 1990. PMID: 2390636 No abstract available.
Graft-versus-host disease: effects on long term disease free survival in marrow transplantation for haematological malignancies.
Kapoor N, Copelan EA, Klein J, Tutschka PJ. Kapoor N, et al. Bone Marrow Transplant. 1989 Dec;4 Suppl 4:153-5. Bone Marrow Transplant. 1989. PMID: 2697430 Clinical Trial. No abstract available.